

［1］Collins AJ，Foley RN，Chavers B，et al.United States Renal Data System 2011 Annual Data Report：Atlas of chronic kidney disease & end-stage renal disease in the United States［J］.AM J Kidney Dis，2012，59(1 Suppl 1)：A7，e1-420. 

［2］ERA-EDTA Registry.ERA-EDTA Registry 2003 Annual Report［J］.Amsterdam，Academic Medical Centre，2005. 

［3］Li LS，Liu ZH.Epidemiologic data of renal diseases from a single unit in China：analysis based on 13 519 renal biopsies［J］.Kidney int，2004，66(3)：920-923. 

［4］Zucchelli P，Zuccalà A.Recent data on hypertension and progressive renal disease［J］.J Hum Hypertens，1996，10(10)：679-682. 

［5］Kincaid-Smith P.Hypothesis：obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled ‘hypertensive nephrosclerosis’［J］.J Hypertens，2004，22(6)：1051-1055. 

［6］Freedman BI，Hicks PJ，Bostrom MA，et al.Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans［J］.Kidney Int，2009，75(7)：736-745. 

［7］Lipkowitz MS，Freedman BI，Langefeld CD，et al.Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans［J］.Kidney Int，2012，25. 

［8］Caetano ER，Zatz R，Saldanha LB，et al.Hypertensive nephrosclerosis as a relevant cause of chronic renal failure［J］.Hypertension，2001，38(2)：171-176. 

［9］Mashima Y，Konta T，Kudo K，et al.Increases in urinary albumin and beta2-microglobulin are independently associated with blood pressure in the Japanese general population：the Takahata Study［J］.Hypertens Res，2011，34(7)：831-835. 

［10］Mashima Y，Konta T，Kudo K，et al.Increases in urinary albumin and beta2-microglobulin are independently associated with blood pressure in the Japanese general population：the Takahata Study［J］.Hypertens Res，2011，34(7)：831-835. 

［11］Palatini P，Mos L，Ballerini P，et al.Relationship between GFR and Albuminuria in Stage 1 Hypertension［J］.Clin J Am Soc Nephrol，2012，27. 

［12］AASK Collaborative Research Group.Intensive blood-pressure control in hypertensive chronic kidney disease［J］.N Engl J Med，2010，363(10)：918-929. 

［13］Kidney Disease：Improving Global Outcomes (KDIGO) Blood Pressure Work Group.KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease［J］.Kidney int，2012，2(suppl)：337-414. 

［14］African American Study of Kidney Disease and Hypertension Study Group.Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease：results from the AASK trial［J］.JAMA，2002，288(19)：2421-2431. 

［15］African American Study of Kidney Disease and Hypertension Study Group.Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis：a randomized controlled trial［J］.JAMA，2001，285(21)：2719-2728. 